Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Saved in:
| Title: | Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. |
|---|---|
| Authors: | Hooper, Perry B.1 (AUTHOR), Farberg, Aaron S.2 (AUTHOR), Fitzgerald, Alison L.3 (AUTHOR), Siegel, Jennifer J.3 (AUTHOR), Rackley, Briana B.3 (AUTHOR), Prasai, Anesh3 (AUTHOR), Kurley, Sarah J.3 (AUTHOR), Goldberg, Matthew S.3 (AUTHOR), Litchman, Graham H.4 (AUTHOR) |
| Source: | Cancer Investigation. Nov2022, Vol. 40 Issue 10, p911-922. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160051576 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hooper%2C+Perry+B%2E%22">Hooper, Perry B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Farberg%2C+Aaron+S%2E%22">Farberg, Aaron S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fitzgerald%2C+Alison+L%2E%22">Fitzgerald, Alison L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siegel%2C+Jennifer+J%2E%22">Siegel, Jennifer J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rackley%2C+Briana+B%2E%22">Rackley, Briana B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prasai%2C+Anesh%22">Prasai, Anesh</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurley%2C+Sarah+J%2E%22">Kurley, Sarah J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldberg%2C+Matthew+S%2E%22">Goldberg, Matthew S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Litchman%2C+Graham+H%2E%22">Litchman, Graham H.</searchLink><relatesTo>4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Investigation%22">Cancer Investigation</searchLink>. Nov2022, Vol. 40 Issue 10, p911-922. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160051576 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/07357907.2022.2116454 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 911 Titles: – TitleFull: Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hooper, Perry B. – PersonEntity: Name: NameFull: Farberg, Aaron S. – PersonEntity: Name: NameFull: Fitzgerald, Alison L. – PersonEntity: Name: NameFull: Siegel, Jennifer J. – PersonEntity: Name: NameFull: Rackley, Briana B. – PersonEntity: Name: NameFull: Prasai, Anesh – PersonEntity: Name: NameFull: Kurley, Sarah J. – PersonEntity: Name: NameFull: Goldberg, Matthew S. – PersonEntity: Name: NameFull: Litchman, Graham H. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 07357907 Numbering: – Type: volume Value: 40 – Type: issue Value: 10 Titles: – TitleFull: Cancer Investigation Type: main |
| ResultId | 1 |
